CLDI Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CLDI shares is 34, representing 2.71% of the company's common stock.

N/A, in the last quarter, reduced its stake in CLDI by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the CLDI shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned CLDI shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, N/A increased its stake in CLDI by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of CLDI to its portfolio, raising its holding to - shares of worth -. N/A also increased its CLDI shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in CLDI is Camaisa Allan , CEO and Chairman of the Board at the company. Additionally, CLDI stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 18.16% percent of Calidi Biotherapeutics, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which CLDI insiders have sold stock, totaling 10K shares. Insiders that have sold shares include CAMAISA ALLAN.

There have been 0 transaction(s) during the past 6-months in which Calidi Biotherapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 66.71K Calidi Biotherapeutics, Inc. shares are held by insiders, which represents about 18.16% of CLDI stock.

CLDI CEO and Chairman of the Board, Camaisa Allan holds the largest portfolio of the company's shares. CLDI shares owned by Camaisa total nearly 66.71 thousand.

N/A is the largest institutional owner in CLDI which holds - shares worth - or N/A of the total CLDI shares outstanding followed by N/A with ownership of - shares representing N/A of the CLDI ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CLDI is concerned, it is a stock which is not optionable.

Number of CLDI shares short is 585.63K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 25.92M shares of CLDI are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CLDI has 5.35M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CLDI is 0.88.